Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
Status:
Recruiting
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to better understand the utility of cannabidiol (CBD/ Epidiolex)
for improving the treatment of cognitive impairments in Sturge-Weber syndrome (SWS).